Halia Therapeutics has completed the enrolment in its Phase IIa trial of HT-6184 (Ofirnoflast) in those with lower-risk ...

My approach to therapy is to provide a supportive environment ... I also provide emotional support animal (ESA) assessment services to determine if you qualify for an ESA letter.

the optimal threshold hemoglobin level for initiation of ESA therapy or blood transfusion and the target hemoglobin level have not been definitively established. Some ongoing Phase III trials ...